ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 202 filers reported holding ANI PHARMACEUTICALS INC in Q1 2024. The put-call ratio across all filers is 8.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,462,984 | -15.3% | 22,974 | -8.0% | 0.01% | -16.7% |
| Q1 2024 | $1,726,453 | +60.0% | 24,974 | +27.6% | 0.01% | +50.0% |
| Q4 2023 | $1,078,869 | -5.7% | 19,566 | -0.7% | 0.00% | -20.0% |
| Q3 2023 | $1,143,492 | -35.4% | 19,695 | -40.1% | 0.01% | -28.6% |
| Q2 2023 | $1,771,222 | – | 32,904 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
| Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
| Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
| Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
| 1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
| THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
| Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
| Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |